Cargando…

The Value of Programmed Death Ligand 1 Expression in Cancer Patients Treated with Neoadjuvant Chemotherapy

Programmed death ligand 1 (PD-L1) is an inhibitory molecule expressed by cancer cells to supress T-cell activity and escape anti-tumour immunity. The role of PD-L1 in cancer has been studied extensively as it is considered an important immune checkpoint against immune over-activation through its int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Dughaishi, Malika, Shalaby, Asem, Al-Ribkhi, Khawla, Boudaka, Ammar, Boulassel, Mohamed-Rachid, Saleh, Jumana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930029/ https://www.ncbi.nlm.nih.gov/pubmed/31897310 http://dx.doi.org/10.18295/squmj.2019.19.04.002

Ejemplares similares

Variation of Programmed Death Ligand 1 Expression After Platinum-based Neoadjuvant Chemotherapy in Lung Cancer
por: Guo, Lei, et al.
Publicado: (2019)

Role of Transient Receptor Potential Vanilloid 4 Channel in Skin Physiology and Pathology
por: Boudaka, Ammar, et al.
Publicado: (2020)

Physiological and Pathological Significance of Esophageal TRP Channels: Special Focus on TRPV4 in Esophageal Epithelial Cells
por: Boudaka, Ammar, et al.
Publicado: (2022)

Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients
por: Park, Woochan, et al.
Publicado: (2021)

Smoking signature is superior to programmed death-ligand 1 expression in predicting pathological response to neoadjuvant immunotherapy in lung cancer patients
por: Yang, Haitang, et al.
Publicado: (2021)

Physiological Intracranial Calcifications in Children: A computed tomography-based study
por: Al Hajri, Faiza, et al.
Publicado: (2023)

Deletion of TRPV4 enhances in vitro wound healing of murine esophageal keratinocytes
por: Boudaka, Ammar, et al.
Publicado: (2020)

Effect of neoadjuvant chemotherapy (NAC) on programmed cell death ligand (PD-L1) in patients of carcinoma breast: A prospective study in Indian tertiary care setting
por: Srivastava, Vipul, et al.
Publicado: (2020)

Prognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis
por: Zhu, Zhenhua, et al.
Publicado: (2017)

Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma
por: Yang, Guozhen, et al.
Publicado: (2021)

Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma
por: Yang, Weixiong, et al.
Publicado: (2022)

Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
por: Yu, Wei-Bo, et al.
Publicado: (2019)

Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
por: Tominaga, Tetsuro, et al.
Publicado: (2019)

Programmed cell death protein 1 is a marker for neoadjuvant chemotherapy response in triple-negative breast cancer
por: Gaui, Maria de Fátima Dias, et al.
Publicado: (2023)

Negative influence of programmed death‐1‐ligands on the survival of esophageal cancer patients treated with chemotherapy
por: Tanaka, Koji, et al.
Publicado: (2016)

Students’ Perceived Benefits of Integrating a BSc in Health Sciences within a Medical Degree at Sultan Qaboos University
por: Boulassel, Mohamed-Rachid, et al.
Publicado: (2020)

Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs
por: Hao, Zhonglin, et al.
Publicado: (2022)

Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis
por: Zhang, Chen, et al.
Publicado: (2021)

Prognostic significance of estrogen, progesterone and HER2 receptors’ status conversion following neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from a tertiary Cancer Center in Saudi Arabia
por: Al-Saleh, Khalid, et al.
Publicado: (2021)

Leishmania Infantum and Epstein-Barr Virus Co-Infection in a Patient with Hemophagocytosis
por: Gaifer, Zied, et al.
Publicado: (2016)

Comparative Analysis of two Methods of Measuring Antiretroviral Therapy Adherence in HIV-Infected Omani Patients
por: Gaifer, Zied, et al.
Publicado: (2019)

Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy
por: Gaifer, Zied, et al.
Publicado: (2020)

Distinct prognostic values of programmed death-ligand 1 and programmed cell death protein 1 in lung adenocarcinoma and squamous cell carcinoma patients
por: Wang, Shuo, et al.
Publicado: (2021)

Prognostic and Clinicopathological Value of Programmed Death Ligand-1 in Breast Cancer: A Meta-Analysis
por: Guo, Yawen, et al.
Publicado: (2016)

Prognostic value of programmed death‐ligand 1 expression in patients with stage III colorectal cancer
por: Koganemaru, Shigehiro, et al.
Publicado: (2017)

The Prognostic Value of Circulating Soluble Programmed Death Ligand-1 in Cancers: A Meta-Analysis
por: Huang, Pei, et al.
Publicado: (2021)

Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma
por: Uemura, Motohide, et al.
Publicado: (2021)

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma
por: Lee, Byung-Hyun, et al.
Publicado: (2021)

Respiratory Viral Infections in Sickle Cell Anemia: Special Emphasis on H1N1 Co-infection
por: Alkindi, Salam, et al.
Publicado: (2020)

Programmed death‐ligand 1 expression in swine chronic infections and enhancement of interleukin‐2 production via programmed death‐1/programmed death‐ligand 1 blockade
por: Ganbaatar, Otgontuya, et al.
Publicado: (2021)

Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy
por: Robl, Bernhard, et al.
Publicado: (2015)

The Evaluation Value of CT in the Efficacy of Neoadjuvant Chemotherapy in Ovarian Cancer Patients
por: Mou, Daying, et al.
Publicado: (2022)

Predictive value of immuno-inflammatory and nutritional measures modulated by neoadjuvant chemotherapy on the response of neoadjuvant chemotherapy and long-term outcomes in patients with esophageal cancer
por: Ishibashi, Yusuke, et al.
Publicado: (2020)

Management of the axilla after neoadjuvant chemotherapy in breast cancer patients
por: Boland, M R, et al.
Publicado: (2021)

Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer
por: Park, Hyunkyung, et al.
Publicado: (2019)

Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value
por: Miglietta, Federica, et al.
Publicado: (2019)

Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis
por: Piao, Jinlan, et al.
Publicado: (2020)

Correction to: Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma
por: Uemura, Motohide, et al.
Publicado: (2021)

Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis
por: Zhang, Yingzi, et al.
Publicado: (2020)

The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response
por: Luo, Min, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_j1e9g2s7tnak7cl4aq4i2p8u7m